Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sinead Jordan

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 10, 2009
Discontinuing disease-modifying therapy in progressive multiple sclerosis: can we stop what we have started?Roisín Lonergan, Katie Kinsella, Marguerite Duggan, et al.
Multiple Sclerosis and Related Disorders|March 20, 2015
Unmet needs of multiple sclerosis patients in the communityRoisin Lonergan, Katie Kinsella, Patricia Fitzpatrick, et al.
Studies in Health Technology and Informatics|October 3, 2025
A Proposed Feasibility Process: Lessons Learned from the Precision MS ProjectSinead Impey, Sinead Jordan, Linda Douris, et al.
Journal of Neurovirology|August 12, 2009
Reactivation of BK polyomavirus in patients with multiple sclerosis receiving natalizumab therapyRoisin M Lonergan, Michael J Carr, Cillian F De Gascun, et al.
Trials|August 29, 2013
Dose-related effects of vitamin D on immune responses in patients with clinically isolated syndrome and healthy control participants: study protocol for an exploratory randomized double- blind placebo-controlled trialKaren O'Connell, Siobhan Kelly, Katie Kinsella, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 5, 2017
Effects of vitamin D<sub>3</sub> in clinically isolated syndrome and healthy control participants: A double-blind randomised controlled trialKaren O'Connell, Jamal Sulaimani, Sharee A Basdeo, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 10, 2009
Discontinuing disease-modifying therapy in progressive multiple sclerosis: can we stop what we have started?Roisín Lonergan, Katie Kinsella, Marguerite Duggan, et al.
Multiple Sclerosis and Related Disorders|March 20, 2015
Unmet needs of multiple sclerosis patients in the communityRoisin Lonergan, Katie Kinsella, Patricia Fitzpatrick, et al.
Studies in Health Technology and Informatics|October 3, 2025
A Proposed Feasibility Process: Lessons Learned from the Precision MS ProjectSinead Impey, Sinead Jordan, Linda Douris, et al.
Journal of Neurovirology|August 12, 2009
Reactivation of BK polyomavirus in patients with multiple sclerosis receiving natalizumab therapyRoisin M Lonergan, Michael J Carr, Cillian F De Gascun, et al.
Trials|August 29, 2013
Dose-related effects of vitamin D on immune responses in patients with clinically isolated syndrome and healthy control participants: study protocol for an exploratory randomized double- blind placebo-controlled trialKaren O'Connell, Siobhan Kelly, Katie Kinsella, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 5, 2017
Effects of vitamin D<sub>3</sub> in clinically isolated syndrome and healthy control participants: A double-blind randomised controlled trialKaren O'Connell, Jamal Sulaimani, Sharee A Basdeo, et al.
Pageof 1